
Roche will invest $240 million in 5 years.
Roche will invest $240 million in 5 years.
414 articles on leadership, communication and professional development.

Roche will invest $240 million in 5 years.

Abbott loses 11% on stock market due to FDA warnings.

AbbVie and Pfizer: Decline in Their Flagship Products

Novo Nordisk seeks alliances against obesity and diabetes.

Eli Lilly obtains approval in Europe to treat Lymphoma.

AstraZeneca drives innovation in primary care.

Alfasigma Acquires Intercept Pharmaceuticals and Adds Ocaliva to its Portfolio

A provocative work that immerses us in the dark world of denial of scientific evidence and its devastating impact on our society and the environment.

The danger of science denial

Why we should trust scientists

How to separate fact and fiction online

Technology in smart watches: the engine of these powerful measurement tools

FDA approves Eli Lilly obesity medication.

From De Novo Nordisk to Roche: Quantum Computing in Search of Drugs and Cures

Boehringer Ingelheim highlighted globally for its CO2 reduction goals

AstraZeneca strengthens fight against obesity with Eccogene

Exports reduce Kimberly Clark's revenues

Sanofi and Fundación ONCE collaborate for inclusion.

TAKEDA BETS ON CANCER, DENGUE, AND GASTRIC HEALTH FOR ITS GROWTH

Bayer Increases Biological Production in Tlaxcala